Official physician headshot used on Zhu Gang's Beijing United Family Hospital profile page.
Beijing United Family Hospital

Gang Zhu

朱刚

Associate Chief Medical Officer, Chair of Urology and Chair of Surgery, United Family Healthcare Beijing Market, Chief Urologist, Urology Consultant, Awarded "China Renowned Doctor"

Urologic oncology and minimally invasive urologic surgery, including robotic, laparoscopic, and endoscopic procedures for prostate, bladder, and kidney disease(泌尿男生殖肿瘤与微创泌尿外科手术,包括前列腺、膀胱、肾脏疾病的机器人、腹腔镜及内镜手术)

Pioneering Contributions

Advanced robotic, laparoscopic, and endoscopic approaches for urologic oncology in Beijing private international practice

Leadership & Positions

  • Associate Chief Medical Officer, United Family Healthcare Beijing Market
  • Chair of Urology and Chair of Surgery, United Family Healthcare Beijing Market
  • Medical Director, Beijing United Family Hospital Dongcheng Campus
  • Council Member, China Anti-Cancer Association (CACA)
  • President, China Anti-Cancer Association Genitourinary Cancer Holistic Rehabilitation Society (CACA-GUHR)
  • Vice Chairman, China Anti-Cancer Association Urological Oncology Committee (CACA-UO)
  • Chair of the Scientific Committee, Asian Robotic Urologic Society (ARUS)

Medical School

Shanghai Medical University (1990)

Graduate

Master of Surgery; PhD in Medicine from King's College London, Peking Union Medical College

Fellowships & Training

King's College Hospital, LondonPostdoctoral research in urology (United Kingdom)

Languages

MandarinEnglish
Request Consultation with Zhu

Notable Publications

Irreversible Electroporation for the Focal Treatment of Prostate Cancer: A Systematic Review.

Cancers (Basel) (2024) — co-author

PubMed/DOI

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients.

World Journal of Urology (2020) — co-author

PubMed/DOI

Urologic cancer in China.

Japanese Journal of Clinical Oncology (2016) — co-author

PubMed/DOI

Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis.

Urologic Oncology (2015) — co-author

PubMed/DOI

Pioneering Contributions

  • Advanced robotic, laparoscopic, and endoscopic approaches for urologic oncology in Beijing private international practice
  • Clinical leadership in focal therapy and image-guided prostate cancer diagnostics, including irreversible electroporation-related work
  • Leadership roles in Chinese and Asian urologic oncology and robotic surgery societies

Sources — Gang Zhu

Request a case review with Gang Zhu

Gang Zhu practices at Beijing United Family Hospital in Beijing.

Request Case Review